18 June 2002
Effects of immunomodulators on acute Trypanosoma Cruzi infection in mice.
Walter T Hughes, Helieh S Oz, Elaine K Thomas, Craig J McClainMed Sci Monit 2002; 8(6): BR208-211 :: ID: 420822
Abstract
BACKGROUND: Patients who recover from acute trypanosomiasis may succumbto chronic Chagas' disease later in life due to age related immunosuppression, immune system disorderssuch as AIDS, or during periods of immunosuppressive therapy for organ transplantation. In this study,effects of immunomodulators with diverse properties were examined on the course of an acute and lethalTrypanosoma cruzi infection.MATERIAL/METHODS: ICR (Swiss) mice inoculated with Tulahuen (lethal) strainof T. cruzi were treated with 6 different immunomodulators and the course of infection was studied.RESULTS:Tacrolimus (FK-506) and dexamethasone increased parasitemia in mice when compared to infected untreatedanimals. Mycophenolate mofetil (RS-61443) and recombinant interleukin-15 (IL-15) treatment decreasedthe number of parasites but had no effect on animal survival. In contrast, compound L-685-818 (tacrolimusanalog) and CD40 ligand (CD40L), provided protection against lethal infection. Mice that survived initialinfection were all protected against reinfection.CONCLUSIONS: This study demonstrates the dangers ofimmunosuppression with tacrolimus and dexamethasone in T. cruzi infected subjects. While mycophenolatedid not exacerbate the infection, our data suggest potential therapeutic applications for L-685-818 andCD40 ligand in trypanosomiasis.
Keywords: Adjuvants, Immunologic, CD40 Ligand, Dexamethasone, Immunosuppressive Agents, Interleukin-15, Mice, Inbred ICR, Mycophenolic Acid, Research Support, Non-U.S. Gov, Research Support, U.S. Gov, Research Support, U.S. Gov, Tacrolimus, Trypanosoma cruzi, Trypanosomiasis
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
08 Mar 2024 : Clinical Research
Evaluation of Foot Structure in Preschool Children Based on Body MassMed Sci Monit In Press; DOI: 10.12659/MSM.943765
15 Apr 2024 : Laboratory Research
The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in OsteoarthritisMed Sci Monit In Press; DOI: 10.12659/MSM.943738
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
08 Mar 2024 : Animal Research
Modification of Experimental Model of Necrotizing Enterocolitis (NEC) in Rat Pups by Single Exposure to Hyp...Med Sci Monit In Press; DOI: 10.12659/MSM.943443
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952